Under certain circumstances, any of the three termination codons can be read through by a near-cognate tRNA; i.e., a tRNA whose two out of three anticodon nucleotides base pair with those of the stop codon. Unless programed to synthetize C-terminally extended protein variants with expanded physiological roles, readthrough represents an undesirable translational error. On the other side of a coin, a significant number of human genetic diseases is associated with the introduction of nonsense mutations (premature termination codons [PTCs]) into coding sequences, where stopping is not desirable. Here, the tRNA's ability to induce readthrough opens up the intriguing possibility of mitigating the deleterious effects of PTCs on human health. In yeast, the UGA and UAR stop codons were described to be read through by four readthrough-inducing rti-tRNAs-tRNATrp and tRNACys, and tRNATyr and tRNAGln, respectively. The readthrough-inducing potential of tRNATrp and tRNATyr was also observed in human cell lines. Here, we investigated the readthrough-inducing potential of human tRNACys in the HEK293T cell line. The tRNACys family consists of two isoacceptors, one with ACA and the other with GCA anticodons. We selected nine representative tRNACys isodecoders (differing in primary sequence and expression level) and tested them using dual luciferase reporter assays. We found that at least two tRNACys can significantly elevate UGA readthrough when overexpressed. This indicates a mechanistically conserved nature of rti-tRNAs between yeast and human, supporting the idea that they could be used in the PTC-associated RNA therapies.

Laboratory of Regulation of Gene Expression Institute of Microbiology ASCR 142 20 Prague the Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc23016433

003      

CZ-PrNML

005      

20231026105836.0

007      

ta

008      

231013s2023 xxu f 000 0|eng||

009      

AR

024    7_

$a 10.1261/rna.079688.123 $2 doi

035    __

$a (PubMed)37221013

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xxu

100    1_

$a Valášek, Leoš Shivaya $u Laboratory of Regulation of Gene Expression, Institute of Microbiology ASCR, 142 20 Prague, the Czech Republic valasekl@biomed.cas.cz p.beznoskova@seznam.cz $1 https://orcid.org/0000000181238667 $7 xx0283089

245    10

$a Cysteine tRNA acts as a stop codon readthrough-inducing tRNA in the human HEK293T cell line / $c LS. Valášek, M. Kučerová, J. Zeman, P. Beznosková

520    9_

$a Under certain circumstances, any of the three termination codons can be read through by a near-cognate tRNA; i.e., a tRNA whose two out of three anticodon nucleotides base pair with those of the stop codon. Unless programed to synthetize C-terminally extended protein variants with expanded physiological roles, readthrough represents an undesirable translational error. On the other side of a coin, a significant number of human genetic diseases is associated with the introduction of nonsense mutations (premature termination codons [PTCs]) into coding sequences, where stopping is not desirable. Here, the tRNA's ability to induce readthrough opens up the intriguing possibility of mitigating the deleterious effects of PTCs on human health. In yeast, the UGA and UAR stop codons were described to be read through by four readthrough-inducing rti-tRNAs-tRNATrp and tRNACys, and tRNATyr and tRNAGln, respectively. The readthrough-inducing potential of tRNATrp and tRNATyr was also observed in human cell lines. Here, we investigated the readthrough-inducing potential of human tRNACys in the HEK293T cell line. The tRNACys family consists of two isoacceptors, one with ACA and the other with GCA anticodons. We selected nine representative tRNACys isodecoders (differing in primary sequence and expression level) and tested them using dual luciferase reporter assays. We found that at least two tRNACys can significantly elevate UGA readthrough when overexpressed. This indicates a mechanistically conserved nature of rti-tRNAs between yeast and human, supporting the idea that they could be used in the PTC-associated RNA therapies.

650    _2

$a lidé $7 D006801

650    _2

$a terminační kodon $x genetika $7 D018388

650    12

$a cystein $x genetika $x metabolismus $7 D003545

650    _2

$a HEK293 buňky $7 D057809

650    12

$a Saccharomyces cerevisiae $x genetika $7 D012441

650    _2

$a RNA transferová Cys $x metabolismus $7 D012350

650    _2

$a RNA transferová Trp $x metabolismus $7 D012364

650    _2

$a RNA transferová Tyr $7 D012365

650    _2

$a RNA transferová $x genetika $x metabolismus $7 D012343

650    _2

$a antikodon $7 D000926

650    _2

$a nesmyslný kodon $x genetika $7 D018389

650    _2

$a proteosyntéza $7 D014176

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Kučerová, Michaela $u Laboratory of Regulation of Gene Expression, Institute of Microbiology ASCR, 142 20 Prague, the Czech Republic

700    1_

$a Zeman, Jakub $u Laboratory of Regulation of Gene Expression, Institute of Microbiology ASCR, 142 20 Prague, the Czech Republic $1 https://orcid.org/000000030545694X

700    1_

$a Beznosková, Petra $u Laboratory of Regulation of Gene Expression, Institute of Microbiology ASCR, 142 20 Prague, the Czech Republic $1 https://orcid.org/0000000207917589

773    0_

$w MED00006007 $t RNA (New York, N.Y.) $x 1469-9001 $g Roč. 29, č. 9 (2023), s. 1379-1387

856    41

$u https://pubmed.ncbi.nlm.nih.gov/37221013 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y - $z 0

990    __

$a 20231013 $b ABA008

991    __

$a 20231026105830 $b ABA008

999    __

$a ok $b bmc $g 2000133 $s 1202795

BAS    __

$a 3

BAS    __

$a PreBMC-MEDLINE

BMC    __

$a 2023 $b 29 $c 9 $d 1379-1387 $e 20230523 $i 1469-9001 $m RNA $n RNA $x MED00006007

LZP    __

$a Pubmed-20231013